“…In addition, pharmaceutical expenditure in hospitals accounted for approximately 40% to 50% of their total income during the past decade [1,4,5,[17][18][19][20]. This arose because the financial support from the Chinese government to public hospitals declined steadily from approximately 60% of hospital revenues in the 1980s to 8.2% by 2003 or lower [5,21]. As a consequence, hospitals in China must necessarily use the revenues from drug procurement and dispensing for their sustainability [3,5,8,17,22].…”